Etrusco A, Mikus M, Damato A, Barra F, Planinic P, Goluza T
Biomedicines. 2024; 12(3).
PMID: 38540265
PMC: 10967775.
DOI: 10.3390/biomedicines12030653.
Che Y, Yu J, Li Y, Zhu Y, Tao T
J Clin Med. 2023; 12(4).
PMID: 36836035
PMC: 9967025.
DOI: 10.3390/jcm12041500.
Malini N, Roy G
Acta Endocrinol (Buchar). 2022; 17(3):313-318.
PMID: 35342460
PMC: 8919493.
DOI: 10.4183/aeb.2021.313.
Gullo G, Etrusco A, Cucinella G, Perino A, Chiantera V, Lagana A
Int J Mol Sci. 2021; 22(21).
PMID: 34769256
PMC: 8583899.
DOI: 10.3390/ijms222111825.
Gambioli R, Oliva M, Nordio M, Chiefari A, Puliani G, Unfer V
Biomedicines. 2021; 9(10).
PMID: 34680494
PMC: 8533370.
DOI: 10.3390/biomedicines9101378.
D-chiro-inositol Induces Ovulation in Non-Polycystic Ovary Syndrome (PCOS), Non-Insulin-Resistant Young Women, Likely by Modulating Aromatase Expression: A Report of 2 Cases.
Espinola M, Lagana A, Bilotta G, Gullo G, Aragona C, Unfer V
Am J Case Rep. 2021; 22:e932722.
PMID: 34615846
PMC: 8503791.
DOI: 10.12659/AJCR.932722.
D-chiro-inositol, an aromatase down-modulator, increases androgens and reduces estrogens in male volunteers: a pilot study.
Monastra G, Vazquez-Levin M, Espinola M, Bilotta G, Lagana A, Unfer V
Basic Clin Androl. 2021; 31(1):13.
PMID: 34078260
PMC: 8173878.
DOI: 10.1186/s12610-021-00131-x.
D-Chiro-Inositol Treatment Affects Oocyte and Embryo Quality and Improves Glucose Intolerance in Both Aged Mice and Mouse Models of Polycystic Ovarian Syndrome.
Pericuesta E, Laguna-Barraza R, Ramos-Ibeas P, Gutierrez-Arroyo J, Navarro J, Vera K
Int J Mol Sci. 2020; 21(17).
PMID: 32842637
PMC: 7504697.
DOI: 10.3390/ijms21176049.
Efficient production of myo-inositol in Escherichia coli through metabolic engineering.
You R, Wang L, Shi C, Chen H, Zhang S, Hu M
Microb Cell Fact. 2020; 19(1):109.
PMID: 32448266
PMC: 7247202.
DOI: 10.1186/s12934-020-01366-5.
Targeting Metabolic Consequences of Insulin Resistance in Polycystic Ovary Syndrome by D-chiro-inositol and Emerging Nutraceuticals: A Focused Review.
Davinelli S, Nicolosi D, Di Cesare C, Scapagnini G, Marco R
J Clin Med. 2020; 9(4).
PMID: 32252239
PMC: 7230532.
DOI: 10.3390/jcm9040987.
An Evaluation of a Nutraceutical with Berberine, Curcumin, Inositol, Banaba and Chromium Picolinate in Patients with Fasting Dysglycemia.
Derosa G, DAngelo A, Vanelli A, Maffioli P
Diabetes Metab Syndr Obes. 2020; 13:653-661.
PMID: 32184644
PMC: 7060772.
DOI: 10.2147/DMSO.S232791.
Current Management of Polycystic Ovary Syndrome: From Bench to Bedside.
Lagana A, Vitale S, Noventa M, Vitagliano A
Int J Endocrinol. 2018; 2018:7234543.
PMID: 30538744
PMC: 6261402.
DOI: 10.1155/2018/7234543.
Polycystic Ovary Syndrome: Implication for Drug Metabolism on Assisted Reproductive Techniques-A Literature Review.
Reyes-Munoz E, Sathyapalan T, Rossetti P, Shah M, Long M, Buscema M
Adv Ther. 2018; 35(11):1805-1815.
PMID: 30311070
PMC: 6224003.
DOI: 10.1007/s12325-018-0810-1.
Oral findings and its association with prenatal and perinatal factors in newborns.
Perez-Aguirre B, Soto-Barreras U, Loyola-Rodriguez J, Reyes-Macias J, Santos-Diaz M, Loyola-Leyva A
Korean J Pediatr. 2018; 61(9):279-284.
PMID: 30274505
PMC: 6172521.
DOI: 10.3345/kjp.2017.06177.
Soy, Soy Foods and Their Role in Vegetarian Diets.
Rizzo G, Baroni L
Nutrients. 2018; 10(1).
PMID: 29304010
PMC: 5793271.
DOI: 10.3390/nu10010043.
Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials.
Unfer V, Facchinetti F, Orru B, Giordani B, Nestler J
Endocr Connect. 2017; 6(8):647-658.
PMID: 29042448
PMC: 5655679.
DOI: 10.1530/EC-17-0243.
Evidence-Based and Patient-Oriented Inositol Treatment in Polycystic Ovary Syndrome: Changing the Perspective of the Disease.
Lagana A, Rossetti P, Sapia F, Chiofalo B, Buscema M, Valenti G
Int J Endocrinol Metab. 2017; 15(1):e43695.
PMID: 28835764
PMC: 5554611.
DOI: 10.5812/ijem.43695.
D-chiro-inositol effectively attenuates cholestasis in bile duct ligated rats by improving bile acid secretion and attenuating oxidative stress.
Zhao S, Li N, Zhao W, Liu H, Ge M, Zhang Y
Acta Pharmacol Sin. 2017; 39(2):213-221.
PMID: 28748913
PMC: 5800478.
DOI: 10.1038/aps.2017.98.
Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols.
Sortino M, Salomone S, Carruba M, Drago F
Front Pharmacol. 2017; 8:341.
PMID: 28642705
PMC: 5463048.
DOI: 10.3389/fphar.2017.00341.
Nutrients as novel therapeutic approaches for metabolic disturbances in polycystic ovary syndrome.
Mansour A, Hosseini S, Larijani B, Mohajeri-Tehrani M
EXCLI J. 2017; 15:551-564.
PMID: 28096785
PMC: 5225686.
DOI: 10.17179/excli2016-422.